{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T20:58:09Z","timestamp":1773694689396,"version":"3.50.1"},"reference-count":57,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.jaut.2009.02.002","type":"journal-article","created":{"date-parts":[[2009,3,10]],"date-time":"2009-03-10T05:35:50Z","timestamp":1236663350000},"page":"140-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Impact of vitamin D receptor activity on experimental autoimmune prostatitis"],"prefix":"10.1016","volume":"32","author":[{"given":"Ruben Dar\u00edo","family":"Motrich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelyne","family":"van Etten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos","family":"Depovere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clelia Maria","family":"Riera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia Elena","family":"Rivero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chantal","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.jaut.2009.02.002_bib1","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1056\/NEJMcp060423","article-title":"Clinical practice. Chronic prostatitis and the chronic pelvic pain syndrome","volume":"355","author":"Schaeffer","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaut.2009.02.002_bib2","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1001\/jama.282.3.236","article-title":"NIH consensus definition and classification of prostatitis","volume":"282","author":"Krieger","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.jaut.2009.02.002_bib3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1146\/annurev.med.57.011205.135654","article-title":"Prostatitis\/chronic pelvic pain syndrome","volume":"57","author":"Habermacher","year":"2006","journal-title":"Annu Rev Med"},{"issue":"1","key":"10.1016\/j.jaut.2009.02.002_bib4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00042307-200201000-00012","article-title":"Understanding chronic pelvic pain syndrome","volume":"12","author":"Bjerklund Johansen","year":"2002","journal-title":"Curr Opin Urol"},{"issue":"1","key":"10.1016\/j.jaut.2009.02.002_bib5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/1097-0045(20000615)44:1<49::AID-PROS7>3.0.CO;2-7","article-title":"PSA is a candidate self-antigen in autoimmune chronic prostatitis\/chronic pelvic pain syndrome","volume":"44","author":"Ponniah","year":"2000","journal-title":"Prostate"},{"issue":"2","key":"10.1016\/j.jaut.2009.02.002_bib6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.clim.2005.03.011","article-title":"Presence of INFgamma-secreting lymphocytes specific to prostate antigens in a group of chronic prostatitis patients","volume":"116","author":"Motrich","year":"2005","journal-title":"Clin Immunol"},{"issue":"9","key":"10.1016\/j.jaut.2009.02.002_bib7","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/humrep\/dei073","article-title":"Reduced semen quality in chronic prostatitis patients that have cellular autoimmune response to prostate antigens","volume":"20","author":"Motrich","year":"2005","journal-title":"Hum Reprod"},{"issue":"2\u20133","key":"10.1016\/j.jaut.2009.02.002_bib8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-3083.2007.01971.x","article-title":"Autoimmune prostatitis: state of the art","volume":"66","author":"Motrich","year":"2007","journal-title":"Scand J Immunol"},{"issue":"1","key":"10.1016\/j.jaut.2009.02.002_bib9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/sj.pcan.4500930","article-title":"Experimental rodent models of prostatitis: limitations and potential","volume":"10","author":"Vykhovanets","year":"2007","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.jaut.2009.02.002_bib10","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0065-2776(08)60490-3","article-title":"The murine autoimmune diabetes model: NOD and related strains","volume":"51","author":"Kikutani","year":"1992","journal-title":"Adv Immunol"},{"issue":"2","key":"10.1016\/j.jaut.2009.02.002_bib11","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1006\/clim.2002.5281","article-title":"Prostatein or steroid binding protein (PSBP) induces experimental autoimmune prostatitis (EAP) in NOD mice","volume":"105","author":"Rivero","year":"2002","journal-title":"Clin Immunol"},{"issue":"6","key":"10.1016\/j.jaut.2009.02.002_bib12","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1006\/jaut.1998.0248","article-title":"Non-obese diabetic (NOD) mice are genetically susceptible to experimental autoimmune prostatitis (EAP)","volume":"11","author":"Rivero","year":"1998","journal-title":"J Autoimmun"},{"issue":"1","key":"10.1016\/j.jaut.2009.02.002_bib13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1615\/CritRevImmunol.v27.i1.30","article-title":"Autoimmune etiology in chronic prostatitis syndrome: an advance in the understanding of this pathology","volume":"27","author":"Rivero","year":"2007","journal-title":"Crit Rev Immunol"},{"issue":"15","key":"10.1016\/j.jaut.2009.02.002_bib14","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.2165\/00002512-200320150-00004","article-title":"Chronic prostatitis\/chronic pelvic pain syndrome in elderly men: toward better understanding and treatment","volume":"20","author":"Pontari","year":"2003","journal-title":"Drugs Aging"},{"issue":"2","key":"10.1016\/j.jaut.2009.02.002_bib15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/jcb.10329","article-title":"Analogs of 1alpha,25\u2212dihydroxyvitamin D3 as pluripotent immunomodulators","volume":"88","author":"van Etten","year":"2003","journal-title":"J Cell Biochem"},{"issue":"5","key":"10.1016\/j.jaut.2009.02.002_bib16","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1210\/er.2004-0002","article-title":"Noncalcemic actions of vitamin D receptor ligands","volume":"26","author":"Nagpal","year":"2005","journal-title":"Endocr Rev"},{"issue":"1\u20132","key":"10.1016\/j.jaut.2009.02.002_bib17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jsbmb.2005.06.009","article-title":"Altered vitamin D receptor\u2013coactivator interactions reflect superagonism of vitamin D analogs","volume":"97","author":"Eelen","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"5","key":"10.1016\/j.jaut.2009.02.002_bib18","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1124\/mol.104.008730","article-title":"Superagonistic action of 14\u2212epi\u2212analogs of 1,25\u2212dihydroxyvitamin D explained by vitamin D receptor\u2212coactivator interaction","volume":"67","author":"Eelen","year":"2005","journal-title":"Mol Pharmacol"},{"issue":"3\u20135","key":"10.1016\/j.jaut.2009.02.002_bib19","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jsbmb.2006.12.094","article-title":"Novel insights in the immune function of the vitamin D system: synergism with interferon-beta","volume":"103","author":"van Etten","year":"2007","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.jaut.2009.02.002_bib20","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S8756-3282(03)00030-9","article-title":"Combination of a 1,25-dihydroxyvitamin D3 analog and a bisphosphonate prevents experimental autoimmune encephalomyelitis and preserves bone","volume":"32","author":"van Etten","year":"2003","journal-title":"Bone"},{"issue":"12","key":"10.1016\/j.jaut.2009.02.002_bib21","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1210\/me.2003-0281","article-title":"A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases","volume":"17","author":"Froicu","year":"2003","journal-title":"Mol Endocrinol"},{"issue":"15","key":"10.1016\/j.jaut.2009.02.002_bib22","doi-asserted-by":"crossref","first-page":"7861","DOI":"10.1073\/pnas.93.15.7861","article-title":"1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis","volume":"93","author":"Cantorna","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.jaut.2009.02.002_bib23","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2337\/db07-1095","article-title":"Unaltered diabetes presentation in nod mice lacking the vitamin D receptor","volume":"57","author":"Gysemans","year":"2008","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.jaut.2009.02.002_bib24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1046\/j.1365-2249.2002.01825.x","article-title":"Treatment of autoimmune diabetes recurrence in non-obese diabetic mice by mouse interferon-beta in combination with an analogue of 1alpha,25\u2212dihydroxyvitamin\u2212D3","volume":"128","author":"Gysemans","year":"2002","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.jaut.2009.02.002_bib25","doi-asserted-by":"crossref","first-page":"957","DOI":"10.4049\/jimmunol.177.2.957","article-title":"Pathogenic consequences in semen quality of an autoimmune response against the prostate gland: from animal models to human disease","volume":"177","author":"Motrich","year":"2006","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.jaut.2009.02.002_bib26","first-page":"33","article-title":"The use of real-time reverse transcriptase PCR for the quantification of cytokine gene expression","volume":"14","author":"Overbergh","year":"2003","journal-title":"J Biomol Tech"},{"key":"10.1016\/j.jaut.2009.02.002_bib27","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2174\/1389557033488204","article-title":"Vitamin D receptor as a drug discovery target","volume":"3","author":"Pinette","year":"2003","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.jaut.2009.02.002_bib28","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1126\/science.6310748","article-title":"1,25\u2212Dihydroxyvitamin D3 receptors in human leukocyte","volume":"221","author":"Provvedini","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.jaut.2009.02.002_bib29","first-page":"457","article-title":"Dendritic cells from human tissues express receptors for the immunomodulatory vitamin D3 metabolite, dihydroxycholecalciferol","volume":"61","author":"Brennan","year":"1987","journal-title":"Immunology"},{"key":"10.1016\/j.jaut.2009.02.002_bib30","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1006\/abbi.1999.1605","article-title":"Expression of 1,25\u2212dihydroxvatamin D3 receptor in the immune system","volume":"374","author":"Veldman","year":"2000","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.jaut.2009.02.002_bib31","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1210\/endo.141.9.7666","article-title":"Vitamin D mediated gene regulation in phenotypically defined B cell subpopulations","volume":"141","author":"Morgan","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.jaut.2009.02.002_bib32","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1096\/fj.01-0433rev","article-title":"Vitamin D: its role and use in immunology","volume":"15","author":"DeLuca","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.jaut.2009.02.002_bib33","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1471-4914(02)02294-3","article-title":"The coming age of 1,25\u2212dihydroxyvitamin D3 analogs as immunomodulatory agents","volume":"8","author":"Mathieu","year":"2002","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.jaut.2009.02.002_bib34","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S1567-5769(02)00049-8","article-title":"Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseases","volume":"2","author":"Adorini","year":"2002","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jaut.2009.02.002_bib35","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0303-7207(85)90074-7","article-title":"Interactions of 1,25\u2212dihydroxyvitamin D3 and the immune system","volume":"43","author":"Manolagas","year":"1985","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.jaut.2009.02.002_bib36","first-page":"68","article-title":"1,25\u2212Dihydroxyvitamin D3 as a natural regulator of human immune functions","volume":"1","author":"Muller","year":"1996","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.jaut.2009.02.002_bib37","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1172\/JCI1050","article-title":"Inhibition of IL\u221212 production by 1,25\u2212dihydroxyvitamin D3","volume":"101","author":"D'Ambrosio","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaut.2009.02.002_bib38","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1172\/JCI113009","article-title":"Granulocyte-macrophage colony-stimulating factor. Sensitive and receptor-mediated regulation by 1,25-dihydroxyvitamin D3 in normal human peripheral blood lymphocytes","volume":"79","author":"Tobler","year":"1987","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.jaut.2009.02.002_bib39","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1002\/eji.200838216","article-title":"1,25-dihydroxyvitamin D(3) promotes IL-10 production in human B cells","volume":"38","author":"Heine","year":"2008","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaut.2009.02.002_bib40","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1084\/jem.20050648","article-title":"The immune paradox of sarcoidosis and regulatory T cells","volume":"203","author":"Miyara","year":"2006","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.jaut.2009.02.002_bib41","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1210\/er.2008-0004","article-title":"Vitamin D and human health: lessons from vitamin D receptor null mice","volume":"29","author":"Bouillon","year":"2008","journal-title":"Endocr Rev"},{"issue":"6 Suppl.","key":"10.1016\/j.jaut.2009.02.002_bib42","doi-asserted-by":"crossref","first-page":"1717S","DOI":"10.1093\/ajcn\/80.6.1717S","article-title":"Vitamin D status, 1,25\u2212dihydroxyvitamin D3, and the immune system","volume":"80","author":"Cantorna","year":"2004","journal-title":"Am J Clin Nutr"},{"issue":"11","key":"10.1016\/j.jaut.2009.02.002_bib43","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1359\/jbmr.2001.16.11.2057","article-title":"In vitro and in vivo analysis of the immune system of vitamin D receptor knockout mice","volume":"16","author":"Mathieu","year":"2001","journal-title":"J Bone Miner Res"},{"issue":"3","key":"10.1016\/j.jaut.2009.02.002_bib44","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1365-2567.2005.02290.x","article-title":"Vitamin D receptor is required to control gastrointestinal immunity in IL\u221210 knockout mice","volume":"117","author":"Froicu","year":"2006","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.jaut.2009.02.002_bib45","doi-asserted-by":"crossref","first-page":"E315","DOI":"10.1152\/ajpendo.00590.2005","article-title":"Increased NF-kappaB activity in fibroblasts lacking the vitamin D receptor","volume":"291","author":"Sun","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jaut.2009.02.002_bib46","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00125-004-1329-3","article-title":"Vitamin D deficiency in early life accelerates type 1 diabetes in non-obese diabetic mice","volume":"47","author":"Giulietti","year":"2004","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.jaut.2009.02.002_bib47","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0003-9861(03)00338-2","article-title":"Oral administration of 1,25-dihydroxyvitamin D3 completely protects NOD mice from insulin-dependent diabetes mellitus","volume":"417","author":"Zella","year":"2003","journal-title":"Arch Biochem Biophys"},{"issue":"2","key":"10.1016\/j.jaut.2009.02.002_bib48","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/jcb.10340","article-title":"Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases","volume":"88","author":"Adorini","year":"2003","journal-title":"J Cell Biochem"},{"issue":"1\u20135","key":"10.1016\/j.jaut.2009.02.002_bib49","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jsbmb.2004.03.017","article-title":"NOD bone marrow-derived dendritic cells are modulated by analogs of 1,25\u2212dihydroxyvitamin D3","volume":"89\u201390","author":"van Etten","year":"2004","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"3","key":"10.1016\/j.jaut.2009.02.002_bib50","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jaut.2004.06.004","article-title":"1alpha,25\u2212dihydroxyvitamin D3 or analogue treated dendritic cells modulate human autoreactive T cells via the selective induction of apoptosis","volume":"23","author":"van Halteren","year":"2004","journal-title":"J Autoimmun"},{"issue":"12","key":"10.1016\/j.jaut.2009.02.002_bib51","doi-asserted-by":"crossref","first-page":"8504","DOI":"10.4049\/jimmunol.177.12.8504","article-title":"Treatment of experimental autoimmune prostatitis in nonobese diabetic mice by the vitamin D receptor agonist elocalcitol","volume":"177","author":"Penna","year":"2006","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.jaut.2009.02.002_bib52","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1572-0241.2002.05549.x","article-title":"Synergistic inhibitory effect of cyclosporin A and vitamin D derivatives on T-lymphocyte proliferation in active ulcerative colitis","volume":"97","author":"Stio","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"10.1016\/j.jaut.2009.02.002_bib53","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1097\/00007890-200005150-00032","article-title":"Analogs of 1,25\u2212dihydroxyvitamin D3 as dose-reducing agents for classical immunosuppressants","volume":"69","author":"van Etten","year":"2000","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.jaut.2009.02.002_bib54","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0165-5728(95)00076-E","article-title":"Prevention of murine experimental allergic encephalomyelitis: cooperative effects of cyclosporine and 1\u03b1,25\u2212(OH)2D3","volume":"61","author":"Branisteanu","year":"1995","journal-title":"J Neuroimmunol"},{"issue":"2","key":"10.1016\/j.jaut.2009.02.002_bib55","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0165-5728(97)00116-1","article-title":"Synergism between sirolimus and 1,25-dihydroxyvitamin D3 in vitro and in vivo","volume":"79","author":"Branisteanu","year":"1997","journal-title":"J Neuroimmunol"},{"issue":"6","key":"10.1016\/j.jaut.2009.02.002_bib56","first-page":"3130","article-title":"Potential role of 1,25(OH)2 vitamin D3 as a dose-reducing agent for cyclosporine and FK 506","volume":"26","author":"Mathieu","year":"1994","journal-title":"Transplant Proc"},{"issue":"5","key":"10.1016\/j.jaut.2009.02.002_bib57","first-page":"3048","article-title":"Activated form of vitamin D [1,25(OH)2D3] and its analogs are dose-reducing agents for cyclosporine in vitro and in vivo","volume":"26","author":"Mathieu","year":"1994","journal-title":"Transplant Proc"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841109000195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841109000195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T07:59:56Z","timestamp":1760255996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841109000195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0896841109000195"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2009.02.002","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of vitamin D receptor activity on experimental autoimmune prostatitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2009.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}